Mozart Therapeutics raises $55M to advance disease therapies By: Puget Sound Business Journal (Seattle) via Business Journals October 26, 2021 at 16:04 PM EDT The Seattle company is developing treatments for celiac disease and inflammatory bowel disease. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
